Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: An open-label study

B. Wilson; M. Rossi; O. Eyice; M. C. Lomer; P. M. Irving; J. O. Lindsay; K. Whelan

doi:10.1017/S0029665119001319

Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: An open-label study

B. Wilson, M. Rossi, O. Eyice, M. C. Lomer, P. M. Irving, J. O. Lindsay, K. Whelan

Research output: Contribution to journal › Meeting abstract › peer-review

1 Citation (Scopus)

Original language	English
Article number	E10
Journal	Proceedings of the Nutrition Society
Volume	79
Issue number	OCE1
DOIs	https://doi.org/10.1017/S0029665119001319
Publication status	Published - 2020

Access to Document

10.1017/S0029665119001319

Cite this

@article{7c3fb0f81b97424ca38773a663c299f7,

title = "Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: An open-label study",

author = "B. Wilson and M. Rossi and O. Eyice and Lomer, {M. C.} and Irving, {P. M.} and Lindsay, {J. O.} and K. Whelan",

year = "2020",

doi = "10.1017/S0029665119001319",

language = "English",

volume = "79",

journal = "Proceedings of the Nutrition Society",

issn = "0029-6651",

publisher = "Cambridge University Press",

number = "OCE1",

}

TY - JOUR

T1 - Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis

T2 - An open-label study

AU - Wilson, B.

AU - Rossi, M.

AU - Eyice, O.

AU - Lomer, M. C.

AU - Irving, P. M.

AU - Lindsay, J. O.

AU - Whelan, K.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85078446022&partnerID=8YFLogxK

U2 - 10.1017/S0029665119001319

DO - 10.1017/S0029665119001319

M3 - Meeting abstract

AN - SCOPUS:85078446022

SN - 0029-6651

VL - 79

JO - Proceedings of the Nutrition Society

JF - Proceedings of the Nutrition Society

IS - OCE1

M1 - E10

ER -

Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: An open-label study

Access to Document

Other files and links

Cite this